Epoch Biodesign closes a 12 million US dollar funding round

UK biotechnology company Epoch Biodesign has closed a 12 million US dollar strategic funding round, including investment from Canadian activewear brand Lululemon, alongside Kompas VC, Happiness Capital, Extantia and Leitmotif (a VC backed by Volkswagen) to accelerate the commercialisation of recycled nylon.